Anthropometric parameters and their relationship to serum growth hormone-binding protein and leptin levels in children with acute lymphoblastic leukemia: A prospective study

European Journal of Endocrinology

Volumn 143, Issue 2, 2000, Pages 243-250

  Arguelles, B ^a   Barrios, V ^a   Buno, M ^a   Madero, L ^a   Argente, J ^a  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE BINDING PROTEIN; LEPTIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTHROPOMETRY; ARTICLE; CHILD; CHILD GROWTH; CHILD NUTRITION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE DETERMINATION; HUMAN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN DETERMINATION; STATISTICAL ANALYSIS;

EID: 0033856360     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1430243     Document Type: Article

References (34)

1. Incidence of cancer in children in the United States
2. Intensification of treatment and survival in children with lymphoblastic leukaemia: Results of UK Medical Research Council trial UKALL X
3. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Munster-based intensive chemotherapy
4. Patterns of obesity in boys and girls after treatment for acute lymphoblastic leukaemia
5. Changes in protein turnover, IGP-I and IGF binding proteins in children with cancer
6. Acquired growth hormone resistance
7. Effects of intensive chemotherapy On bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia
8. Obesity after successful treatment of acute lymphoblastic leukemia in childhood
9. Final height and weight of long-term survivors of childhood malignancies
10. Leptin levels are strongly correlated with those of GH-binding protein in prepubertal children
11. Editorial: Leptin and puberty
12. Leptin and clinical medicine: A new piece in the puzzle of obesity
13. Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the 'BFM Family' cooperative group
14. Curvas y Tablas de Crecimiento
15. A longitudinal study of growth and growth hormone secretion in children during treatment for acute lymphoblastic leukemia
16. Pituitary hormone secretion and growth after cranial irradiation. Therapeutic consequences
17. Growth in the irradiated child
18. Measurement of human growth hormone receptor messenger ribonucleic acid by a quantitative polymerase chain reaction-based assay: Demonstration of reduced expression after elective surgery
19. Long-term effects of treatment for acute lymphoblastic leukemia with and without cranial irradiation on growth and puberty; a comparative study
20. Growth and growth hormone in children during and after therapy for acute lymphoblastic leukaemia
21. Nonparallel changes of growth hormone (GH) and insulin-like growth factor-I, insulin-like growth factor binding protein-3, and GH-binding protein, after craniospinal irradiation and chemotherapy
22. Longitudinal study of the ternary complex of human insulin-like growth factors (IGFs) in children with acute lymphoblastic leukemia
23. The role of body mass in the response to growth hormone therapy
24. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: Effect of short and long-term weight recuperation
25. High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood
26. Growth, puberty and obesity after treatment for leukemia
27. Influence of treatment modalities on body weight in acute lymphoblastic leukemia
28. An anthropometric study of children during intensive chemotherapy for acute lymphoblastic leukaemia
29. Role of leptin in the neuroendocrine response to fasting
30. Obesity, leptin, and the brain
31. Plasma leptin levels in healthy children and adolescents: Dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone
32. Tumor necrosis factor increases serum leptin levels in humans
33. Leptina: Implicaciones clinicas
34. Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood